Mosquera, Juan Miguel

Publications

Sort by

Co-Author Network

selected publications

Functional genomics pipeline identifies CRL4 inhibition for the treatment of ovarian cancer. Clinical and translational medicine. 2025 Academic Article GET IT
Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition. Cancer research. 2025 Academic Article GET IT
Mesonephric Adenocarcinoma in a Young Male Patient. 2025 GET IT
Unusual Presentation of Advanced Urothelial Cancer in a Young Patient. 2025 GET IT
Corrigendum to "Whole genome and transcriptome analysis of pancreatic acinar cell carcinoma elucidates mechanisms of homologous recombination deficiency and unravels novel relevant fusion events" [Pathol. - Res. Pract. 266 (2025) 155798]. 2025 GET IT
Whole genome and transcriptome analysis of pancreatic acinar cell carcinoma elucidates mechanisms of homologous recombination deficiency and unravels novel relevant fusion events. Pathology, research and practice. 2024 Academic Article GET IT
Emerging molecular phenotypes and potential therapeutic targets in esophageal and gastric adenocarcinoma unearthed by whole genome and transcriptome analyses. Pathology, research and practice. 2024 Academic Article GET IT
Novel structural variants that impact cell cycle genes are elucidated in metastatic gastrointestinal stromal tumors. Pathology, research and practice. 2024 Academic Article GET IT
Enhancing the detection of clinically relevant biomarkers in advanced uterine and tubo-ovarian carcinomas through genome-wide analysis. Pathology, research and practice. 2024 Academic Article GET IT
Whole genome profiling of primary and metastatic adrenocortical carcinoma unravels significant molecular events. Pathology, research and practice. 2024 Academic Article GET IT
Increased translation driven by non-canonical EZH2 creates a synthetic vulnerability in enzalutamide-resistant prostate cancer. Nature communications. 2024 Academic Article GET IT
Whole genome profiling of rare pediatric thoracic tumors elucidates a YAP1::LEUTX fusion in an unclassified biphasic embryonal neoplasm. 2024 GET IT
Whole genome sequencing elucidates etiological differences in MCPyV-negative Merkel cell carcinoma. 2024 GET IT
The interplay of mutagenesis and ecDNA shapes urothelial cancer evolution. Nature. 2024 Academic Article GET IT
Detection of rare and novel gene fusions in patients with diffuse glioma: An institutional retrospective study. Journal of neuropathology and experimental neurology. 2024 Academic Article GET IT
Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: Germline Risk Factors in a Prospective Cohort. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2024 Academic Article GET IT
Integrative Transcriptomic and Single-Cell Protein Characterization of Colorectal Carcinoma Delineates Distinct Tumor Immune Microenvironments Associated with Overall Survival. 2024 GET IT
Notch signaling suppresses neuroendocrine differentiation and alters the immune microenvironment in advanced prostate cancer. The Journal of clinical investigation. 2024 Academic Article GET IT
Multinational, Multicenter Evaluation of Prostate Cancer Tissue in Sub-Saharan Africa: Challenges and Opportunities. JCO global oncology. 2024 Academic Article GET IT
Optimization of Fluorescence In Situ Hybridization Protocols in the Era of Precision Medicine. Current protocols. 2024 Academic Article GET IT
Incidental seminoma in nonobstructive azoospermia: a case report. F&S reports. 2024 Academic Article GET IT
The evolution of metastatic upper tract urothelial carcinoma through genomic-transcriptomic and single-cell protein markers analysis. Nature communications. 2024 Academic Article GET IT
Whole-Genome Sequencing Analysis of Male Breast Cancer Unveils Novel Structural Events and Potential Therapeutic Targets. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2024 Academic Article GET IT
Cooperativity of c-MYC with Krüppel-Like Factor 6 Splice Variant 1 induces phenotypic plasticity and promotes prostate cancer progression and metastasis. 2024 GET IT
Deciphering the origin and therapeutic targets of cancer of unknown primary: a case report that illustrates the power of integrative whole-exome and transcriptome sequencing analysis. 2024 GET IT
NIPBL::NACC1 Fusion Hepatic Carcinoma. The American journal of surgical pathology. 2023 Academic Article GET IT
Author Correction: Evolution of structural rearrangements in prostate cancer intracranial metastases. 2023 GET IT
Evolution of structural rearrangements in prostate cancer intracranial metastases. NPJ precision oncology. 2023 Academic Article GET IT
The importance of escalating molecular diagnostics in patients with low-grade pediatric brain cancer. Cold Spring Harbor molecular case studies. 2023 Academic Article GET IT
Long-molecule scars of backup DNA repair in BRCA1- and BRCA2-deficient cancers. Nature. 2023 Academic Article GET IT
The Immunogenomic Landscape of Neuroendocrine Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2023 Academic Article GET IT
Whole-genome characterization of myoepithelial carcinomas of the soft tissue. Cold Spring Harbor molecular case studies. 2022 Academic Article GET IT
Unsupervised discovery of tissue architecture in multiplexed imaging. Nature methods. 2022 Academic Article GET IT
GLI1-Rearranged Enteric Tumor: Expanding the Spectrum of Gastrointestinal Neoplasms with GLI1 gene fusions. The American journal of surgical pathology. 2022 Academic Article GET IT
Identifying synergistic high-order 3D chromatin conformations from genome-scale nanopore concatemer sequencing. Nature biotechnology. 2022 Academic Article GET IT
Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets. Science (New York, N.Y.). 2022 Academic Article GET IT
Weakly-supervised tumor purity prediction from frozen H&E stained slides. EBioMedicine. 2022 Academic Article GET IT
Inhibition of FGF receptor blocks adaptive resistance to RET inhibition in CCDC6-RET-rearranged thyroid cancer. The Journal of experimental medicine. 2022 Academic Article GET IT
Times cited: 11
A multidisciplinary approach to optimize primary prostate cancer biobanking. Urologic oncology. 2022 Academic Article GET IT
RET Fusion-Positive Papillary Thyroid Cancers are Associated with a More Aggressive Phenotype. Annals of surgical oncology. 2022 Academic Article GET IT
Times cited: 7
The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy. Molecular oncology. 2022 Academic Article GET IT
Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studies. The Journal of pathology. 2022 Academic Article GET IT
Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer foci. JCI insight. 2022 Academic Article GET IT
Serial ctDNA analysis predicts clinical progression in patients with advanced urothelial carcinoma. British journal of cancer. 2022 Academic Article GET IT
Extracellular Matrix in Synthetic Hydrogel-based Prostate Cancer Organoids Regulate Therapeutic Response to EZH2 and DRD2 inhibitors. Advanced materials (Deerfield Beach, Fla.). 2021 Academic Article GET IT
Molecular Evaluation of Low-grade Low-stage Endometrial Cancer With and Without Recurrence. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists. 2021 Academic Article GET IT
Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis. NPJ precision oncology. 2021 Academic Article GET IT
Functional comparison of exome capture-based methods for transcriptomic profiling of formalin-fixed paraffin-embedded tumors. NPJ genomic medicine. 2021 Academic Article GET IT
Validation of a Circulating Tumor DNA-Based Next-Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing. The oncologist. 2021 Academic Article GET IT
Targeting the epichaperome as an effective precision medicine approach in a novel PML-SYK fusion acute myeloid leukemia. NPJ precision oncology. 2021 Academic Article GET IT
Times cited: 25
Incorporating cytologic adequacy assessment into precision oncology workflow using telepathology: An institutional experience. Cancer cytopathology. 2021 Academic Article GET IT
Common germline-somatic variant interactions in advanced urothelial cancer. Nature communications. 2020 Academic Article GET IT
Times cited: 24
Performance Characteristics of a Targeted Sequencing Platform for Simultaneous Detection of Single Nucleotide Variants, Insertions/Deletions, Copy Number Alterations, and Gene Fusions in Cancer Genome. Archives of pathology & laboratory medicine. 2020 Academic Article GET IT
Times cited: 1
Feasibility of in-office MRI-targeted partial gland cryoablation for prostate cancer: an IDEAL stage 2A study. BMJ surgery, interventions, & health technologies. 2020 Academic Article GET IT
Times cited: 11
Integration of whole-exome and anchored PCR-based next generation sequencing significantly increases detection of actionable alterations in precision oncology. Translational oncology. 2020 Academic Article GET IT
Times cited: 10
Distinct Classes of Complex Structural Variation Uncovered across Thousands of Cancer Genome Graphs. Cell. 2020 Academic Article GET IT
Times cited: 142
Contemporary Results and Clinical Utility of Renal Mass Biopsies in the Setting of Ablative Therapy: A single center experience. Cancer treatment and research communications. 2020 Academic Article GET IT
Molecular Profiles of Mixed Endometrial Carcinoma. The American journal of surgical pathology. 2020 Academic Article GET IT
Times cited: 3
Neuroendocrine differentiation in usual-type prostatic adenocarcinoma: Molecular characterization and clinical significance. The Prostate. 2020 Academic Article GET IT
Times cited: 4
Next-generation sequencing of residual cytologic fixative preserved DNA from pancreatic lesions: A pilot study. Cancer cytopathology. 2020 Academic Article GET IT
Times cited: 1
Fusions involving BCOR and CREBBP are rare events in infiltrating glioma. Acta neuropathologica communications. 2020 Academic Article GET IT
Times cited: 20
Adenomyoepithelial tumors of the breast: molecular underpinnings of a rare entity. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2020 Academic Article GET IT
Times cited: 4
Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes. Nature communications. 2020 Academic Article GET IT
Times cited: 45
Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer. The Journal of clinical investigation. 2020 Academic Article GET IT
Times cited: 128
SLFN11 Expression in Advanced Prostate Cancer and Response to Platinum-based Chemotherapy. Molecular cancer therapeutics. 2020 Academic Article GET IT
Prostate Multiparametric Magnetic Resonance Imaging Features Following Partial Gland Cryoablation. Urology. 2020 Academic Article GET IT
Times cited: 2
Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer. JCO precision oncology. 2019 Academic Article GET IT
Times cited: 33
Clinical features of neuroendocrine prostate cancer. European journal of cancer. 2019 Academic Article GET IT
Times cited: 221
Race and prostate imaging: implications for targeted biopsy and image-based prostate cancer interventions. BMJ surgery, interventions, & health technologies. 2019 Academic Article GET IT
Times cited: 1
Cancer-Specific Thresholds Adjust for Whole Exome Sequencing-based Tumor Mutational Burden Distribution. JCO precision oncology. 2019 Academic Article GET IT
Times cited: 27
The Clinical Utility of the Genomic Prostate Score in Men with Very Low to Intermediate Risk Prostate Cancer. The Journal of urology. 2019 Academic Article GET IT
Times cited: 2
Genomic correlates of clinical outcome in advanced prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. 2019 Academic Article GET IT
Times cited: 872
Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer. Science translational medicine. 2019 Academic Article GET IT
Times cited: 138
Gynecologic Organ Involvement During Radical Cystectomy for Bladder Cancer: Is It Time to Routinely Spare the Ovaries?. Clinical genitourinary cancer. 2018 Academic Article GET IT
Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate. Molecular cancer research : MCR. 2018 Academic Article GET IT
Times cited: 48
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers. Clinical cancer research : an official journal of the American Association for Cancer Research. 2018 Academic Article GET IT
Times cited: 198
Patient derived organoids to model rare prostate cancer phenotypes. Nature communications. 2018 Academic Article GET IT
Times cited: 264
Bone biopsy protocol for advanced prostate cancer in the era of precision medicine. Cancer. 2017 Academic Article GET IT
Times cited: 45
SPOP mutation drives prostate neoplasia without stabilizing oncogenic transcription factor ERG. The Journal of clinical investigation. 2017 Academic Article GET IT
Times cited: 27
Aberrant Activation of a Gastrointestinal Transcriptional Circuit in Prostate Cancer Mediates Castration Resistance. Cancer cell. 2017 Academic Article GET IT
Times cited: 58
A Precious Diagnostic "Pearl": The Necklace Pattern in Germ Cell Tumors of the Testis. 2017 GET IT
Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomics. Journal of translational medicine. 2017 Academic Article GET IT
Times cited: 6
Molecular alterations in prostate cancer and association with MRI features. Prostate cancer and prostatic diseases. 2017 Academic Article GET IT
Times cited: 13
Next-Generation Rapid Autopsies Enable Tumor Evolution Tracking and Generation of Preclinical Models. JCO precision oncology. 2017 Academic Article GET IT
Times cited: 43
Characterization of CD34-deficient myofibroblastomas of the breast. The breast journal. 2017 Academic Article GET IT
Times cited: 3
Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function ERF Mutations. Cancer discovery. 2017 Academic Article GET IT
Times cited: 96
Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase Inhibition. European urology. 2017 Academic Article GET IT
Times cited: 17
On-site Cytology for Development of Patient-Derived Three-dimensional Organoid Cultures - A Pilot Study. Anticancer research. 2017 Academic Article GET IT
Times cited: 5
Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine. Cancer discovery. 2017 Academic Article GET IT
Times cited: 750
Clonal evolution of chemotherapy-resistant urothelial carcinoma. Nature genetics. 2016 Academic Article GET IT
Times cited: 233
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer. Cancer cell. 2016 Academic Article GET IT
Times cited: 412
Characterization of the leiomyomatous variant of myofibroblastoma: a rare subset distinct from other smooth muscle tumors of the breast. Human pathology. 2016 Academic Article GET IT
Times cited: 4
Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care. NPJ genomic medicine. 2016 Academic Article GET IT
Times cited: 68
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. Nature medicine. 2016 Academic Article GET IT
Times cited: 1204
Intracellular location of BRCA2 protein expression and prostate cancer progression in the Swedish Watchful Waiting Cohort. Carcinogenesis. 2016 Academic Article GET IT
Times cited: 6
Clonal evaluation of prostate cancer foci in biopsies with discontinuous tumor involvement by dual ERG/SPINK1 immunohistochemistry. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2016 Academic Article GET IT
Times cited: 24
The Initial Detection and Partial Characterization of Circulating Tumor Cells in Neuroendocrine Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2015 Academic Article GET IT
Times cited: 114
The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer. Cell reports. 2015 Academic Article GET IT
Times cited: 135
Integrative Clinical Genomics of Advanced Prostate Cancer. 2015 GET IT
Times cited: 228
Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response. JAMA oncology. 2015 Academic Article GET IT
Times cited: 234
Integrative clinical genomics of advanced prostate cancer. Cell. 2015 Academic Article GET IT
Times cited: 2587
Multicenter Evaluation of the Prostate Health Index to Detect Aggressive Prostate Cancer in Biopsy Naïve Men. The Journal of urology. 2015 Academic Article GET IT
Times cited: 143
ERG induces taxane resistance in castration-resistant prostate cancer. Nature communications. 2014 Academic Article GET IT
Times cited: 102
The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer. Nature communications. 2014 Academic Article GET IT
Times cited: 539
Organoid cultures derived from patients with advanced prostate cancer. Cell. 2014 Academic Article GET IT
Times cited: 1186
Unraveling the clonal hierarchy of somatic genomic aberrations. Genome biology. 2014 Academic Article GET IT
Times cited: 82
MYB-NFIB gene fusion in adenoid cystic carcinoma of the breast with special focus paid to the solid variant with basaloid features. Human pathology. 2014 Academic Article GET IT
Times cited: 44
Evidence for molecular differences in prostate cancer between African American and Caucasian men. Clinical cancer research : an official journal of the American Association for Cancer Research. 2014 Academic Article GET IT
Times cited: 135
Prostate cancer with Paneth cell-like neuroendocrine differentiation has recognizable histomorphology and harbors AURKA gene amplification. Human pathology. 2014 Academic Article GET IT
Times cited: 30
Proposed morphologic classification of prostate cancer with neuroendocrine differentiation. The American journal of surgical pathology. 2014 Academic Article GET IT
Times cited: 436
Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2014 Academic Article GET IT
Times cited: 24
SPOP mutations in prostate cancer across demographically diverse patient cohorts. Neoplasia (New York, N.Y.). 2014 Academic Article GET IT
Times cited: 123
Diagnostic utility of MYC amplification and anti-MYC immunohistochemistry in atypical vascular lesions, primary or radiation-induced mammary angiosarcomas, and primary angiosarcomas of other sites. Human pathology. 2013 Academic Article GET IT
Times cited: 63
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nature biotechnology. 2013 Academic Article GET IT
Times cited: 1748
Novel MIR143-NOTCH fusions in benign and malignant glomus tumors. Genes, chromosomes & cancer. 2013 Academic Article GET IT
Times cited: 146
V-ets erythroblastosis virus E26 oncogene homolog (avian)/Trefoil factor 3/high-molecular-weight cytokeratin triple immunostain: a novel tissue-based biomarker in prostate cancer with potential clinical application. Human pathology. 2013 Academic Article GET IT
Times cited: 5
Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Academic Article GET IT
Times cited: 1721
Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma. Genes, chromosomes & cancer. 2013 Academic Article GET IT
Times cited: 458
Frequent PLAG1 gene rearrangements in skin and soft tissue myoepithelioma with ductal differentiation. Genes, chromosomes & cancer. 2013 Academic Article GET IT
Times cited: 128
Punctuated evolution of prostate cancer genomes. Cell. 2013 Academic Article GET IT
Times cited: 1024
Epigenomic alterations in localized and advanced prostate cancer. Neoplasia (New York, N.Y.). 2013 Academic Article GET IT
Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma. Genes, chromosomes & cancer. 2013 Academic Article GET IT
Times cited: 202
Dedifferentiation in gastrointestinal stromal tumor to an anaplastic KIT-negative phenotype: a diagnostic pitfall: morphologic and molecular characterization of 8 cases occurring either de novo or after imatinib therapy. The American journal of surgical pathology. 2013 Academic Article GET IT
Times cited: 89
Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer. Prostate cancer and prostatic diseases. 2013 Academic Article GET IT
Times cited: 61
Novel dual-color immunohistochemical methods for detecting ERG-PTEN and ERG-SPINK1 status in prostate carcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2013 Academic Article GET IT
Times cited: 42
Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing. Nature genetics. 2013 Academic Article GET IT
Times cited: 645
Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer. Neoplasia (New York, N.Y.). 2013 Academic Article GET IT
Times cited: 205
Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression. Cancer research. 2012 Academic Article GET IT
Times cited: 157
Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity. European urology. 2012 Academic Article GET IT
Times cited: 370
Loss of SPINK1 expression is associated with unfavorable outcomes in urothelial carcinoma of the bladder after radical cystectomy. Urologic oncology. 2012 Academic Article GET IT
Times cited: 9
Oncogene-mediated alterations in chromatin conformation. Proceedings of the National Academy of Sciences of the United States of America. 2012 Academic Article GET IT
Times cited: 115
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nature genetics. 2012 Academic Article GET IT
Times cited: 1255
Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinomas. Diagnostic molecular pathology : the American journal of surgical pathology, part B. 2011 Academic Article GET IT
Times cited: 54
Novel ZEB1 expression in bladder tumorigenesis. BJU international. 2010 Academic Article GET IT
Times cited: 45
Identification of the transcription factor single-minded homologue 2 as a potential biomarker and immunotherapy target in prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2009 Academic Article GET IT
Times cited: 145
Expanding the spectrum of malignant progression in solitary fibrous tumors: a study of 8 cases with a discrete anaplastic component--is this dedifferentiated SFT?. The American journal of surgical pathology. 2009 Academic Article GET IT
Times cited: 162
Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States. Clinical cancer research : an official journal of the American Association for Cancer Research. 2009 Academic Article GET IT
Times cited: 205
Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications. Clinical cancer research : an official journal of the American Association for Cancer Research. 2008 Academic Article GET IT
Times cited: 180
Integrative microarray analysis of pathways dysregulated in metastatic prostate cancer. Cancer research. 2007 Academic Article GET IT
Times cited: 60
TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion. The American journal of surgical pathology. 2007 Academic Article GET IT
Times cited: 336
Morphological features of TMPRSS2-ERG gene fusion prostate cancer. The Journal of pathology. 2007 Academic Article GET IT
Times cited: 103
TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort. Oncogene. 2007 Academic Article GET IT
Times cited: 515
TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. Cancer research. 2006 Academic Article GET IT
Times cited: 417
Tumor gene expression and prognosis in breast cancer patients with 10 or more positive lymph nodes. Clinical cancer research : an official journal of the American Association for Cancer Research. 2005 Academic Article GET IT
Times cited: 167
The phosphorylated form of connexin43 is up-regulated in breast hyperplasias and carcinomas and in their neoformed capillaries. Human pathology. 2005 Academic Article GET IT
Times cited: 14
Immunolocalization of the Epstein-Barr nuclear antigen-1 in conjunctival squamous carcinomas and dysplasias. Human pathology. 2005 Academic Article GET IT
Times cited: 8
Oestrogen receptors alpha and beta differ in normal human breast and breast carcinomas. The Journal of pathology. 2002 Academic Article GET IT
Times cited: 85

more ...

less ...

Research

Sort by

Co-investigator Network

Funding awarded

missing activity Principal Investigator 2021 - 2025
missing activity Principal Investigator 2020 - 2024

missing activity Co-Investigator 2025 - 2027
missing activity Co-Investigator 2024 - 2025

more ...

less ...

Background

education and training

M.D., National University of Colombia Faculty of Medicine (Colombia) 94
M.Sc., University of Leicester (United Kingdom) 2000

Contact

full name

Juan Miguel Mosquera

primary email

jmm9018@med.cornell.edu

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Juan Miguel Mosquera Professor of Pathology and Laboratory Medicine

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email

webpage

Phone

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email

webpage